Pancreatic Cancer Research

ResearcherWashington University in St. LouisActive in the last 2 years

Parag Jitendra Parikh

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 6 November 2026

Matched on OpenAlex author ID A5112349731. Sources: ClinicalTrials.gov.

Their work

Papers
13 (first author 2, last author 2)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
106
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 3 papers, 1 trial · 2020: none · 2021: 2 papers · 2022: none · 2023: 3 papers · 2024: 3 papers

Papers 13

  1. Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label… Last author DOI 10.1016/j.radonc.2023.110064↗
  2. The Use of MR-Guided Radiation Therapy for Pancreatic Cancer. First author DOI 10.1016/j.semradonc.2023.10.002↗
  3. Stereotactic body radiotherapy plus rucosopasem in locally advanced or borderline resectable pancreatic cancer: GRECO-2 phase II study design. Co-author DOI 10.2217/fon-2022-1219↗
  4. MR-Guided Radiation Therapy With Concurrent Gemcitabine/Nab-Paclitaxel Chemotherapy in Inoperable Pancreatic Cancer: A TITE-CRM Phase I Trial. Co-author DOI 10.1016/j.ijrobp.2022.07.015↗
  5. A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable… Co-author DOI 10.1016/j.ijrobp.2023.05.023↗
  6. Impact of intrafraction motion in pancreatic cancer treatments with MR-guided adaptive radiation therapy. Co-author DOI 10.3389/fonc.2023.1298099↗
  7. Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma. Co-author DOI 10.1200/jco.21.01220↗
  8. Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions. Co-author DOI 10.3389/fonc.2021.628155↗
  9. Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer. Co-author DOI 10.1002/cam4.2100↗
  10. Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis. Co-author DOI 10.1093/jnci/djz073↗
  11. Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results. First author DOI 10.1186/s13014-019-1309-x↗
  12. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic … Co-author DOI 10.1186/s13014-018-1000-7↗
  13. Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pa… Last author DOI 10.1097/coc.0000000000000003↗

Trials 1

  1. Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer Principal investigator NCT03621644↗

Closest collaborators

The 25 strongest of 106 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Percy P. Lee · 4 shared papers, 1 shared trial, 2019–2024 · strength 0.66
  2. William Adrian Hall · 3 shared papers, 2021–2024 · strength 0.57
  3. Daniel A. Low · 2 shared papers, 1 shared trial, 2019–2024 · strength 0.48
  4. Lois A. Daamen · 2 shared papers, 2021–2024 · strength 0.46
  5. Michael Frederick Bassetti · 4 shared papers, 2019–2024 · strength 0.46
  6. Hyun Jee Kim · 3 shared papers, 2023–2024 · strength 0.41
  7. Lauren E. Henke · 3 shared papers, 2023–2024 · strength 0.41
  8. Michael David Chuong · 3 shared papers, 2021–2024 · strength 0.37
  9. Christopher H. Crane · 3 shared papers, 2019–2021 · strength 0.37
  10. Lorraine Portelance · 3 shared papers, 2019–2024 · strength 0.35
  11. Joseph M. Herman · 2 shared papers, 2021–2024 · strength 0.30
  12. Sarah E. Hoffe · 2 shared papers, 2021–2024 · strength 0.30
  13. John Ng · 2 shared papers, 2023–2024 · strength 0.27
  14. Luca Boldrini · 2 shared papers, 2023–2024 · strength 0.27
  15. Kathryn Elizabeth Mittauer · 2 shared papers, 2023–2024 · strength 0.27
  16. Alex T. Price · 2 shared papers, 2023–2024 · strength 0.27
  17. Lorenzo Placidi · 2 shared papers, 2023–2024 · strength 0.27
  18. Adam Christopher Mueller · 2 shared papers, 2023–2024 · strength 0.27
  19. Bassem I. Zaki · 2 shared papers, 2023–2024 · strength 0.27
  20. Joseph Douglas Mancias · 2 shared papers, 2023–2024 · strength 0.27
  21. Andrea Wang‐Gillam · 3 shared papers, 2016–2023 · strength 0.25
  22. Jennifer L. Dolan · 1 shared paper, 2023 · strength 0.22
  23. Doris N. Rusu · 1 shared paper, 2023 · strength 0.22
  24. Michael Chuong · 1 shared trial, 2019 · strength 0.21
  25. William G. Hawkins · 2 shared papers, 2016–2023 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.